Exhibit 9 AMENDED AND RESTATED -------------------- SIDE AGREEMENT --------------Side Agreement • November 30th, 2001 • Coolsavings Com Inc • Services-business services, nec • New York
EXHIBIT 10.31 SIDE AGREEMENT This Side Agreement ("Agreement") is made as of the 16th day of March, 2005 by and among Clearwire Corporation, a Delaware corporation (the "Company"), Eagle River Holdings, LLC, a Washington limited liability company...Side Agreement • January 8th, 2007 • Clearwire Corp • Communications services, nec • Delaware
EX-10.7 12 ff12015ex10vii_pvnanocell.htm SIDE AGREEMENT SIDE AGREEMENTSide Agreement • May 5th, 2020
This Side Agreement (“Letter”) is entered into as of July 20, 2014, by and between P.V. Nanocell Ltd., an Israeli company (“Company”), and IP Bank International (Suzhou) Co., Ltd. (“IPB”).
SIDE AGREEMENTSide Agreement • June 17th, 2020 • Dow Inc. • Plastic materials, synth resins & nonvulcan elastomers • Delaware
SIDE AGREEMENT, dated as of June 13, 2020 (this “Agreement”), entered into by and among AgroFresh Solutions, Inc., a Delaware corporation (the “Company”), PSP AGFS Holdings, L.P., a Delaware limited partnership (“Investor”) and Rohm and Haas Company, a Delaware corporation (together with its affiliates, “Dow”).
EXHIBIT 10.31 SIDE AGREEMENT This Side Agreement ("Agreement") is made as of the 16th day of March, 2005 by and among Clearwire Corporation, a Delaware corporation (the "Company"), Eagle River Holdings, LLC, a Washington limited liability company...Side Agreement • March 7th, 2007 • Clearwire Corp • Communications services, nec • Delaware
EX-10.34 4 d273446dex1034.htm SIDE AGREEMENT Execution Copy SIDE AGREEMENTSide Agreement • May 5th, 2020
Reference is made to the (i) Exclusive License Agreement dated December 8, 2005 (the “License Agreement”) by and between the University of Iowa Research Foundation (“UIRF”) and OvaMed GmbH (“OvaMed” or “LICENSEE”), and (ii) exclusive Sublicense Agreement dated December 12, 2005, as amended (the “Sublicense Agreement”) by and between OvaMed and Coronado Biosciences, Inc., as successor to Asphelia Pharmaceuticals, Inc. (“Asphelia”) and Collingwood Pharmaceuticals, Inc. (“Coronado”).
SIDE AGREEMENTSide Agreement • October 5th, 2005 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
REFERENCE IS MADE to (i) the License Agreement effective as of September 26, 2003, by and between RUSH-PRESBYTERIAN-ST. LUKE’S MEDICAL CENTER, an Illinois not-for-profit corporation and having its principal office at 1725 W. Harrison St. Chicago, Ill. 60612 (“Rush”), and ACORDA THERAPEUTICS, INC., a corporation organized and existing under the laws of the State of Delaware and having its principal office at 15 Skyline Drive, Hawthorne, New York 10532 (“Acorda”) (the “Rush/Acorda License”), and (ii) the Amended and Restated License and Supply Agreement effective as of September 26, 2003 by and between Acorda and ELAN CORPORATION, PLC., a public limited company incorporated under the laws of Ireland and having its registered office at Lincoln House, Lincoln Place, Dublin 2, Ireland (“Elan”) (the “Elan/Acorda License”). The Rush/Acorda License and the Elan/Acorda License are sometimes collectively referred to herein as the “Novation Agreements”.
ContractSide Agreement • August 24th, 2015 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
SIDE AGREEMENTSide Agreement • March 20th, 2018 • CollPlant Holdings Ltd. • Orthopedic, prosthetic & surgical appliances & supplies
Reference is made to that certain Securities Purchase Agreement dated as of November 9, 2017 among CollPlant Holdings Ltd. (the “Company”), and Ami Sagi 70291935, an Israeli citizen (“Ami”) (including its successors and assigns), including any Schedules, Annexes and Exhibits thereto, as may be amended, supplemented or otherwise modified from time to time (“Purchase Agreement”).
SIDE AGREEMENTSide Agreement • January 7th, 2008 • Cascal B.V.
• Both Cascal and Biwater individually lease a part of the office Premises numbered 6.1.24 — hereinafter the “Premises” — located at Strawinskylaan 3105, 1077 ZX Amsterdam, the Netherlands, from Equity Trust Co. N. V. — hereinafter the “Lessor” — on the basis of written lease agreements; see Annex 1, hereinafter the “Lease Agreements”.
SIDE AGREEMENT WITH BASKET PARTNERSSide Agreement • September 15th, 2008
Side Agreement Real EstateSide Agreement • May 24th, 2022
lnetcratrnosnmegigartaivtedaannddfirceo-nadnudp-blicriamtestSonilveioStsetipllhdaisnpursonpeovrteiornesnhcaisphsiuplpatoesiprraetlrigoinoiuzisnlyglwy.hSeancCliklientPenarfsriafacltusrteillsvhieiss:bfaelwklienset.and
From: Hammond, JamesSide Agreement • November 17th, 2023
SIDE AGREEMENTSide Agreement • March 20th, 2018 • CollPlant Holdings Ltd. • Orthopedic, prosthetic & surgical appliances & supplies
Reference is made to that certain Securities Purchase Agreement dated as of November 7, 2017 among CollPlant Holdings Ltd. (the “Company”), and Meitav Dash Provident Funds And Pension Ltd., a company organized under the laws of the State of Israel (including its successors and assigns, a “Purchaser”), including any Schedules, Annexes and Exhibits thereto, as may be amended, supplemented or otherwise modified from time to time (“Purchase Agreement”).
Side Agreement in relation to the ISDA European Variance Swap Protocol, published by ISDA on February 5, 2008Side Agreement • November 24th, 2022
We refer to the ISDA European Variance Swap Protocol (the "Variance Protocol") published on February 5, 2008 by the International Swaps and Derivatives Association, Inc. ("ISDA"). This letter constitutes a side agreement for the purpose of satisfying the Side Letter Condition set out in Annex 3 to the Variance Protocol. Capitalized terms used but not defined in this letter have the meanings given to those terms in the Variance Protocol.
Side Agreement between VUSD and VUEA Contract Agreement between theSide Agreement • August 26th, 2020
For those bargaining unit members who have opted to receive a district-issued laptop during the COVID- 19 pandemic/full-distance learning, both the VUSD and VUEA agree to the following interpretation of Exhibit E to Administrative Regulation 3512 (Request to Check Out Electronic & Technology Equipment):
SIDE AGREEMENT to the License Agreement dated 1st July 2016 between UCB Biopharma Sprl and Syndax Pharmaceuticals, Inc. (“License Agreement”)Side Agreement • May 9th, 2017 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
This side agreement (this “Agreement”) is entered into as of the latest date of signature appearing below by and between UCB Biopharma Sprl, a Belgian corporation with offices located at Allée de la Recherche 60, 1070 Brussels, Belgium (“UCB”) and Syndax Pharmaceuticals, Inc. a Delaware corporation with offices located at 35 Gatehouse Drive, Building D, Floor 3, Waltham, Massachusetts 02451, USA (“Company”). UCB and Company are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.
Dated 18 July 2006 POLY TECHNOLOGIES, INC. and FERRARI S.p.A. and ITALIAN MOTORS (SALES & SERVICE) LTD and CTF LUXURY GOODS (CHINA) LIMITED SIDE AGREEMENT relating to Amended and Restated Equity Joint Venture Contract in respect of Ferrari Maserati...Side Agreement • September 8th, 2006 • Xact Aid Inc • Pharmaceutical preparations
Side Agreement between VUSD and VUEA Contract of Agreement betweenSide Agreement • July 31st, 2020
Given the learning time needed for educators to adjust to distance learning management, significant time during the nine (9) day Orientation at the beginning of the school year will be devoted to planning time and access to professional development.
ContractSide Agreement • August 8th, 2007 • Remote MDX Inc • Electronic & other electrical equipment (no computer equip) • Utah
Side Agreement Between the San Francisco Community College District and the American Federation of Teachers Local 2121Side Agreement • November 10th, 2009
SIDE AGREEMENTSide Agreement • March 30th, 2011 • Iveda Solutions, Inc. • Operative builders • California
This Side Agreement, dated as of March 21, 2011, is entered into by and among Iveda Solutions, Inc., a Nevada corporation (“Iveda”), Sole-Vision Technologies, Inc. (doing business as MegsSys), a corporation organized under the laws of the Republic of China (“MegaSys”), and the shareholders of MegaSys identified on Exhibit A and the signature pages hereto (“MegaSys Shareholders”).
Side Agreement in relation to the Stand-alone 2007 Americas Master Variance Swap Confirmation Agreement, published by ISDA on January 30, 2007Side Agreement • October 6th, 2022
We refer to the ISDA Equity MCA Protocol (the “ISDA Equity MCA Protocol”) published on September 18, 2007 by the International Swaps and Derivatives Association, Inc. (“ISDA”). This letter constitutes a side agreement for the purpose of satisfying the Side Letter Condition as referred to in Section 2(b)(B) of the ISDA Equity MCA Protocol. Capitalized terms used herein have the meaning ascribed to them in Section 6 of the ISDA Equity MCA Protocol or the 2002 ISDA Equity Derivatives Definitions, as appropriate.
ContractSide Agreement • November 19th, 2021 • Exicure, Inc. • Pharmaceutical preparations
SIDE AGREEMENTSide Agreement • January 23rd, 2018 • CollPlant Holdings Ltd. • Orthopedic, prosthetic & surgical appliances & supplies
Reference is made to that certain Securities Purchase Agreement dated as of September 6, 2017 among CollPlant Holdings Ltd. (the “Company”), and the purchaser signatory thereto (such purchaser, including its successors and assigns, a “Purchaser”), including any Schedules, Annexes and Exhibits thereto, as may be amended, supplemented or otherwise modified from time to time (“Purchase Agreement”).
SIDE AGREEMENT BETWEEN HEALTH BASKET FINANCING PARTNERS AND THE GOVERNMENT OF TANZANIA, FISCAL YEAR 2009/10Side Agreement • December 18th, 2009
To BLUE SKYE (LUX) S.À R.L. 26, rue Philippe II, L-2340, Luxembourg Attention: Lorenzo Patrassi Telefax: +352 2673 8432; with copy to:Side Agreement • August 16th, 2007 • Kemet Corp • Electronic components & accessories
Further to our recent understandings, we hereby propose to enter into this side agreement in connection with the sale and purchase of the entire corporate capital of Arcotronics Italia S.p.A. with you on the terms and conditions set forth in the proposal attached.
Confidential and Proprietary Information of Aspen Aerogels Side Agreement between BASF SE and Aspen Aerogels, Inc.Side Agreement • August 5th, 2016 • Aspen Aerogels Inc • Wholesale-lumber & other construction materials
This Side Agreement is made the latest date set forth below (the “Effective Date”) by BASF SE, Carl-Bosch-Straße 38, 67056 Ludwigshafen, Germany (“BASF”) and Aspen Aerogels, Inc., 30 Forbes Road, Building B, Northborough, MA 01532, United States of America (“ASPEN”). BASF and ASPEN are each individually referred to as a “Party” and collectively as the “Parties”.
Side Agreement – OMFS Off-Duty and Call CompensationSide Agreement • January 5th, 2024
CIR/SEIU and Alameda Health System (“The Parties”) agree to the criteria set forth below for premium pay for residents in the Oral and Maxillofacial Surgery (“OMFS”) program. This Side Letter is intended to clarify and/or supersede the application of Article 16 of the MOU to OMFS residents.
Side Agreement Meaning In AuditSide Agreement • July 28th, 2021
ptSeeurdmpepinsletoalRolliganinged.siZ.eabcehlearbieorvoarlosrwisaedsdtleetshossocmoepilcyaslilny.thImermeaintaufrteelry, Vhoewrgeilviaenr,frDoegrgbiyesctloPsaudrdeide ucnotnhsintrkuinctgmneisstsruasntidngdlyykoinrg
SIDE AGREEMENT OF HAVRE GLOBAL ABSide Agreement • April 19th, 2021 • Oatly Group AB • Food and kindred products
WHEREAS, Verlinvest and CRC indirectly own the Lead Investor through CRVV and the Lead Investor in turn directly owns Shares in the Company;
CONFIDENTIAL TREATMENT REQUESTED SIDE AGREEMENT to the Collaboration and License Agreement between Sanofi, Sanofi-Pasteur and PierisSide Agreement • February 17th, 2015 • Pieris Pharmaceuticals, Inc. • Services-commercial physical & biological research
This side agreement (“Side Agreement”) is made and entered into on the date of last signature of this Side Agreement as indicated below, and will be effective as of November 28, 2014 (“Effective Date”) by and between Sanofi and Sanofi-Pasteur Inc. (collectively, “Sanofi”) and Pieris AG (“Pieris”).
PROPOSED SIDE AGREEMENT BETWEEN SEIU LOCAL 1021 AND THESide Agreement • September 2nd, 2020
This Side Agreement is entered into by and between Peralta Community College District (“PCCD” or “District”) and the Service Employees International Union 1021 and its Chapter (together “SEIU”) concerning the District’s response to the coronavirus (COVID-19) pandemic, and effective upon execution by both parties (April , 2020).
SIDE AGREEMENTSide Agreement • July 13th, 2017 • California
THIS SIDE AGREEMENT (this “Agreement”), dated as of July 13, 2017, is entered into by ANI Development, LLC, a California limited liability company (“ANI”), in favor of Ovation Finance Holdings 2 LLC, a Nevada limited liability company (“Ovation”).
Re: Side Agreement to “Northwestern Agreements” in Relation to Purdue SublicenseSide Agreement • November 7th, 2017 • Exicure, Inc. • Pharmaceutical preparations
Reference is hereby made to that certain License Agreement executed on February 10, 2016 and effective as of May 27, 2014, to that certain License Agreement executed and effective on June 17, 2016, and that certain Restated License Agreement amended on September 27, 2016 and effective as of December 12, 2011 (collectively, the “Northwestern Agreements”) by and between Northwestern University, an Illinois not-for-profit corporation with a principal place of business at 633 Clark Street, Evanston, Illinois, 60208 (“Northwestern”), and Exicure, Inc., a Delaware corporation with a principal place of business at 8045 Lamon Avenue, Skokie, Illinois, 60077 (“Exicure”).
